These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Rapid and Quantitative Intraoperative Pathology-Assisted Surgery by Paired-Agent Imaging-Derived Confidence Map. Wang C; Hodge S; Ravi D; Chen EY; Hoopes PJ; Tichauer KM; Samkoe KS Mol Imaging Biol; 2023 Feb; 25(1):190-202. PubMed ID: 36315374 [TBL] [Abstract][Full Text] [Related]
24. Epidermal growth factor-targeted fluorescence is unaffected by standard neoadjuvant therapies in human sarcomas. Henderson ER; Werth P; Xu X; Jarvis LA; Paulsen KD; Hoopes PJ; Rosenthal EL; Pogue BW; Samkoe KS Proc SPIE Int Soc Opt Eng; 2022; 119430():. PubMed ID: 36052271 [TBL] [Abstract][Full Text] [Related]
25. Evaluation of fluorescence-guided surgery agents in a murine model of soft tissue fibrosarcoma. Prince AC; McGee AS; Siegel H; Rosenthal EL; Behnke NK; Warram JM J Surg Oncol; 2018 May; 117(6):1179-1187. PubMed ID: 29284070 [TBL] [Abstract][Full Text] [Related]
26. Effect of nonspecific binding of imaging agents to plasma protein in the paired-agent imaging for resection during surgery (PAIRS). Xu X; Tichauer KM; Samkoe KS Proc SPIE Int Soc Opt Eng; 2020 Feb; 11219():. PubMed ID: 34121794 [TBL] [Abstract][Full Text] [Related]
27. Near-infrared fluorescence laparoscopy of the ureter with three preclinical dyes in a pig model. van den Bos J; Al-Taher M; Bouvy ND; Stassen LPS Surg Endosc; 2019 Mar; 33(3):986-991. PubMed ID: 30478696 [TBL] [Abstract][Full Text] [Related]
28. Dual-labeled trastuzumab-based imaging agent for the detection of human epidermal growth factor receptor 2 overexpression in breast cancer. Sampath L; Kwon S; Ke S; Wang W; Schiff R; Mawad ME; Sevick-Muraca EM J Nucl Med; 2007 Sep; 48(9):1501-10. PubMed ID: 17785729 [TBL] [Abstract][Full Text] [Related]
29. Improved decision making for prioritizing tumor targeting antibodies in human xenografts: Utility of fluorescence imaging to verify tumor target expression, antibody binding and optimization of dosage and application schedule. Dobosz M; Haupt U; Scheuer W MAbs; 2017 Jan; 9(1):140-153. PubMed ID: 27661454 [TBL] [Abstract][Full Text] [Related]
30. Site-specific radiometal labeling and improved biodistribution using ABY-027, a novel HER2-targeting affibody molecule-albumin-binding domain fusion protein. Orlova A; Jonsson A; Rosik D; Lundqvist H; Lindborg M; Abrahmsen L; Ekblad C; Frejd FY; Tolmachev V J Nucl Med; 2013 Jun; 54(6):961-8. PubMed ID: 23528382 [TBL] [Abstract][Full Text] [Related]
31. uPAR-targeted optical near-infrared (NIR) fluorescence imaging and PET for image-guided surgery in head and neck cancer: proof-of-concept in orthotopic xenograft model. Christensen A; Juhl K; Persson M; Charabi BW; Mortensen J; Kiss K; Lelkaitis G; Rubek N; von Buchwald C; Kjær A Oncotarget; 2017 Feb; 8(9):15407-15419. PubMed ID: 28039488 [TBL] [Abstract][Full Text] [Related]
32. NIRDye 812: A molecular platform tailored for multimodal bioimaging applications of targeted fluorescence- and photoacoustic-guided surgery. Hettie KS; Chin FT J Photochem Photobiol B; 2023 May; 242():112683. PubMed ID: 36934549 [TBL] [Abstract][Full Text] [Related]
34. Influence of composition of cysteine-containing peptide-based chelators on biodistribution of Oroujeni M; Andersson KG; Steinhardt X; Altai M; Orlova A; Mitran B; Vorobyeva A; Garousi J; Tolmachev V; Löfblom J Amino Acids; 2018 Aug; 50(8):981-994. PubMed ID: 29728916 [TBL] [Abstract][Full Text] [Related]
35. Evaluation of optical imaging agents in a fluorescence-guided surgical model of head and neck cancer. Prince AC; Moore LS; Tipirneni KE; Ramesh T; Limdi MA; Bevans SL; Walsh EM; Greene B; Rosenthal EL; Warram JM Surg Oncol; 2018 Jun; 27(2):225-230. PubMed ID: 29937175 [TBL] [Abstract][Full Text] [Related]
36. Simultaneous extracellular and intracellular quantification of EGFR using paired-agent imaging in an Samkoe KS; Schultz E; Solanki A; Wang L; Korber J; Tichauer KM; Gibbs SL Proc SPIE Int Soc Opt Eng; 2019 Feb; 10859():. PubMed ID: 32296254 [TBL] [Abstract][Full Text] [Related]
37. SPECT- and fluorescence image-guided surgery using a dual-labeled carcinoembryonic antigen-targeting antibody. Rijpkema M; Oyen WJ; Bos D; Franssen GM; Goldenberg DM; Boerman OC J Nucl Med; 2014 Sep; 55(9):1519-24. PubMed ID: 24982436 [TBL] [Abstract][Full Text] [Related]
38. Intraoperative near-infrared fluorescence tumor imaging with vascular endothelial growth factor and human epidermal growth factor receptor 2 targeting antibodies. Terwisscha van Scheltinga AG; van Dam GM; Nagengast WB; Ntziachristos V; Hollema H; Herek JL; Schröder CP; Kosterink JG; Lub-de Hoog MN; de Vries EG J Nucl Med; 2011 Nov; 52(11):1778-85. PubMed ID: 21990576 [TBL] [Abstract][Full Text] [Related]
39. Paired-agent imaging as a rapid Torres VC; Hodge S; Levy JJ; Vaickus LJ; Chen EY; LeBouef M; Samkoe KS Front Oncol; 2023; 13():1196517. PubMed ID: 37427140 [TBL] [Abstract][Full Text] [Related]